Last edition
News about Drug Discovery & Development
Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis
Drug Discovery & Development | 21/07/2023 | By Sudeep Soparkar | 925
Oman plans new global vaccine, drug development factory: Report
Opal Bio Pharma (OBP), a pharmaceutical company in Oman, has begun the construction of the country’s first factory dedicated to manufacturing essential medicines and vaccines. The foundation stone for this groundbreaking facility was laid at Khazaen Economic City, with an estimated cost of OMR60 million ($156 million).
Drug Discovery & Development | 17/07/2023 | By Sudeep Soparkar | 1554
GeneQuantum Healthcare and Aimed Bio collaborate to develop five innovative ADC drugs
GeneQuantum Healthcare and Aimed Bio collaborate to develop five innovative ADC drugs
Drug Discovery & Development | 10/07/2023 | By Sudeep Soparkar | 694
Sanyou Forms Partnership with Hangzhou Zhongmei Huadong Pharmaceutical, Catalyzing Innovative Drug Research and Development
Drug Discovery & Development | 06/07/2023 | By Sudeep Soparkar | 360
Sterline's Robotic Solution To Process Fatro's Small Batches Of Single-Dose PFs For Veterinary Vaccines
Drug Discovery & Development | 27/06/2023 | By Sudeep Soparkar | 786
H.E.L Group Introduces Two New Bioreactors to Support Bioprocess Development
H.E.L Group has announced the expansion of its BioXplorer range with two new automated parallel bioreactors.
Drug Discovery & Development | 08/06/2023 | By Manvi | 894
Platform leverages proprietary PUREcoli™ strain and cutting-edge screening packages for unmatched efficiencies and optimized production processes
Drug Discovery & Development | 08/06/2023 | By Sudeep Soparkar | 675
Integration of Sartorius' process scale multi-column chromatography with Waters' process analytical technology to provide robust analytical data for downstream biomanufacturing of mAbs, recombinant proteins, vaccines, and other biologics.
Drug Discovery & Development | 08/06/2023 | By Sudeep Soparkar | 675
PlasmaGen Biosciences ('PlasmaGen'), a biopharmaceutical company focused on blood plasma-derived pharmaceutical products for India and emerging markets, recently celebrated the official opening of the company's new manufacturing plant for blood plasma-derived protein therapeutics in Kolar, Bengaluru.
Drug Discovery & Development | 31/05/2023 | By Sudeep Soparkar | 1516
Zydus Announces USFDA's Rubber-Stampfor Ephedrine Sulfate Injection
Ephedrine Sulfate Injection is advised for the treatment of clinically significant hypotension that occurs during anaesthesia.
Drug Discovery & Development | 17/05/2023 | By Manvi | 674
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy